Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Population-based cohort study of the effect of endometrial cancer classification and treatment criteria on long-term survival

Artikel i vetenskaplig tidskrift
Författare T. Svanvik
Karin Sundfeldt
Ulf Strömberg
Erik Holmberg
J. Marcickiewicz
Publicerad i International Journal of Gynecology & Obstetrics
Volym 138
Nummer/häfte 2
Sidor 183-189
ISSN 0020-7292
Publiceringsår 2017
Publicerad vid Institutionen för kliniska vetenskaper, sektionen för onkologi, radiofysik, radiologi och urologi
Institutionen för kliniska vetenskaper, sektionen för kvinnors och barns hälsa, Avdelningen för obstetrik och gynekologi
Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för hälsometri
Sidor 183-189
Språk English
Länkar doi.org/10.1002/ijgo.12214
Ämnesord Adjuvant therapy, Endometrial cancer, Relative survival, gynecologic-oncology-group, phase-iii trial, intermediate-risk, postoperative radiotherapy, adjuvant chemotherapy, randomized-trials, dna-ploidy, mrc astec, carcinoma, surgery, Obstetrics & Gynecology
Ämneskategorier Klinisk medicin

Sammanfattning

Objective: To evaluate if increased individualization in endometrial cancer classification/treatment affected relative survival. Methods: The present retrospective register-based population study included data from all women in the western Swedish healthcare region who were treated for endometrial cancer between January 1, 1995, and December 31, 2011. Outcomes and prognostic data were retrieved from the western Swedish healthcare region's cancer and clinical endometrial cancer registries. Patients were stratified based on two different treatment programs (cohort 1 January 1, 1995, to September 10, 2006, and cohort 2 September 11, 2006, to December 31, 2011) and relative survival was compared. Results: Data from 4338 patients were included; 2936 in cohort 1 and 1402 in cohort 2. Among endometrioid endometrial carcinomas, the 5-year relative survival rate for did not differ significantly between the groups (P=0.751); radiotherapy was used more frequently in cohort 1 (P<0.001). Among non-endometrioid endometrial carcinomas, relative survival was lower in cohort 1 (P=0.006); radiotherapy use was more frequent in cohort 1 and chemotherapy use was more frequent in cohort 2 (P<0.001). Conclusion: Increased individualization in endometrioid endometrial cancer management did not improve relative survival. Improved relative survival was observed for non-endometrioid endometrial cancer; possibly due to increased adjuvant chemotherapy use.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?